ExodusPoint Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

ExodusPoint Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,513	Closed	-$397K	–	2862
2020 Q4	$397K	Buy	5,513 +80	+1%	+$4.19K	﹤0.01%	1385
2020 Q3	$248K	Buy	+5,433	New	+$227K	﹤0.01%	1377

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

ExodusPoint Capital Management's BEAT Position: Q1 2021 in Review

ExodusPoint Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 5,513 shares — an estimated $397K sold.

ExodusPoint Capital Management first reported a position in BEAT in Q3 2020 and held it in 2 quarters. The position peaked at $397K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

ExodusPoint Capital Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
ExodusPoint Capital Management sold 5,513 BioTelemetry, Inc. shares in Q1 2021, an estimated $397K.
ExodusPoint Capital Management first reported a position in BioTelemetry, Inc. in Q3 2020 and held it in 2 quarters.
ExodusPoint Capital Management's BioTelemetry, Inc. position peaked at $397K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on ExodusPoint Capital Management's 13F filing for Q1 2021, filed 17 May 2021.